Clinical trials
Phase 1 Hypertension trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
98 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 9 |
| 2015 | 10 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 9 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 11 |
| 2023 | 10 |
| 2024 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 81 |
| Unknown status | 9 |
| Not yet recruiting | 5 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chong Kun Dang Pharmaceutical | 39 |
| Boryung Pharmaceutical Co., Ltd | 18 |
| Yuhan Corporation | 8 |
| Addpharma Inc. | 6 |
| HK inno.N Corporation | 4 |
| Hanlim Pharm. Co., Ltd. | 3 |
| AJU Pharm Co., Ltd. | 2 |
| HanAll BioPharma Co., Ltd. | 2 |
| Huons Co., Ltd. | 2 |
| JW Pharmaceutical | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 98 |
| Dyslipidemias | 25 |
| Hyperlipidemias | 21 |
| Diabetes Mellitus, Type 2 | 4 |
| Essential Hypertension | 2 |
| Angina, Stable | 1 |
| Diabetes Mellitus | 1 |
| Heart Failure | 1 |
| Hypercholesterolemia | 1 |
| Peripheral Arterial Disease | 1 |
Trials
Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.